Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identifiers![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identifiers
URI: http://hdl.handle.net/20.500.11940/5714
PMID: 21148630
DOI: 10.1530/EJE-10-0867
ISSN: 0804-4643
Date issued
2011Journal title
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Type of content
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)